Novo Nordisk (NVO) stock in focus as the company promotes FDA-approved Wegovy as a ban for makers of compounding versions ...

U.S. stocks are set to wrap a winning week as tariff and trade fears ease, President Trump winds down his Middle East trip ...

Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Galaxy Digital's (GLXY) debut on the Nasdaq, Eli Lilly (LLY) getting a lift ...

Drug maker Novo Nordisk (NVO) said on Friday that Lars Fruergaard Jørgensen will step down as CEO, sending shares down 4% in pre-market trading. Jørgensen, appointed CEO in January 2017 ...

Novo Nordisk CEO Lars Fruergaard Jørgensen to step down amid board and market pressure. Despite leadership changes, the company maintains its strategy. Unlock your all-in-one trading dashboard ...

Novo Nordisk's share price fell on the news, trading 3% lower by 1133 GMT after trading 4% higher earlier in the day. The shares are down 32% year-to-date and 59% from the all-time high in June ...

The move in futures comes after a broadly positive day on Wall Street. The S&P 500 rose 0.72%, while the Nasdaq Composite climbed 1.61% for its fifth straight positive session. The Dow fell 0.64%, ...

On Wednesday afternoon, the Fed left interest rates unchanged at a range of 4.25% to 4.5% for the third straight meeting. The ...

U.S.-listed shares of Novo Nordisk (NVO) are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered its full-year outlook. The maker of blockbuster weight-loss ...

MASH prevalence in Canada is projected to rise from 5.2% to 6.5% by 2030. Health Canada review could lead to the first approved treatment for MASH. Memorial Day Special: Access your full investing ...

Novo Nordisk has submitted an "Ozempic pill" to the FDA for approval. The new pill will probably be popular (if approved). However, making it will require Novo Nordisk to ramp up semaglutide ...